Phytopharm
Phytopharm Klęka S.A. is a Polish pharmaceutical company, part of Europlant Group, that manufactures plant-based medicinal products for prevention and treatment, sold through wholesalers and pharmacies, with additional B2B services in contract manufacturing, out-licensing, and API sales.
- Company typePrivate
- Founded1949
- HeadquartersNowe Miasto Nad Warta, Poland
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Phytopharm does
Phytopharm Klęka S.A. is a research-based pharmaceutical company headquartered in Klęka, Poland (Nowe Miasto nad Wartą), specializing in the manufacture of plant-derived medicinal products for prevention and treatment. The company produces herbal/phytopharmaceutical products using high-quality active ingredients with proven effectiveness and confirmed safety, operating under a registered pharmaceutical company structure with Marketing Authorization (MA) and Regulatory Affairs (RA) capabilities. Phytopharm is a subsidiary of the Europlant Group, a pan-European pharmaceutical group focused on plant-based medicines, sharing corporate branding, contact infrastructure, and the europlant-group.pl domain.
The company's commercial model operates through multiple channels. Its primary revenue stream is the sale of branded plant-based pharmaceutical products to wholesalers and pharmacies in the Polish domestic market. Beyond finished-product distribution, Phytopharm maintains dedicated B2B sales channels for contract manufacturing, out-licensing, and API/extract sales, targeting external pharmaceutical clients. The company is managed by a three-member board (Managing Director, Managing Director Finance, Managing Director Operations) and has a registered share capital of PLN 20,000,000. The company is registered as a Polish S.A. (public limited company) with KRS No. 0000051392, but its shares are not listed on any stock exchange, making it a privately held entity within the Europlant Group structure.
Phytopharm firmographics
Firmographics- Name
- Phytopharm
- Legal name
- Phytopharm Klęka S.A.
- Website
- https://phytopharm.com.pl
- Company type
- Private
- Founded year
- 1949
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Phytopharm Klęka S.A. is a Polish pharmaceutical company, part of Europlant Group, that manufactures plant-based medicinal products for prevention and treatment, sold through wholesalers and pharmacies, with additional B2B services in contract manufacturing, out-licensing, and API sales.
- Ownership category
- akta.pro rank
Phytopharm industry classification
Industry- Product category
- Herbal Pharmaceuticals
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)
Keywords
Where Phytopharm is headquartered
LocationHeadquarters
- HQ city
- Nowe Miasto Nad Warta
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
Phytopharm business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical product sales: Sale of plant-based pharmaceutical products for prevention and treatment, sold through wholesalers and pharmacies
Go-to-market motion1 record
Distribution channels3 records
Marketing channels2 records
Phytopharm product offering
Product offeringCore offering
Phytopharm Klęka S.A. develops, manufactures and markets plant-based (herbal/phytopharmaceutical) medicinal products for prevention and treatment of various health conditions. Its portfolio includes finished herbal medicinal products sold under its own brand through wholesale and pharmacy channels. In addition, the company provides contract manufacturing services for other pharmaceutical partners and out-licenses its proprietary plant-derived products and active pharmaceutical ingredients (APIs).
Product overview
Phytopharm Klęka S.A. is a research-based pharmaceutical company specializing in plant-derived medicinal products for prevention and treatment. The company manufactures products using high-quality active ingredients with proven effectiveness and confirmed safety. Their product portfolio includes multiple branded herbal/phytopharmaceutical products sold primarily to pharmacies and wholesalers, with offerings spanning both consumer-facing brands and contract manufacturing services for the pharmaceutical industry. The company operates as part of the Europlant Group.
Differentiator
Problem solved
Functional benefit
Products and services
- Phytopharm branded herbal medicinal products Plant-based (phytopharmaceutical) medicinal products developed and manufactured by Phytopharm for prevention and treatment of various health conditions, sold under the Phytopharm brand through pharmaceutical wholesalers and pharmacies.
- Contract manufacturing services B2B contract manufacturing of plant-based medicinal products offered to other pharmaceutical companies, leveraging Phytopharm's phytopharmaceutical manufacturing infrastructure, regulatory expertise and plant-derived active ingredient capabilities.
- Out-licensing of products and APIs Out-licensing of Phytopharm's proprietary plant-based medicinal products and active pharmaceutical ingredients (APIs) to pharmaceutical partners for sale and distribution in markets outside Poland.
Companies that use Phytopharm
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Phytopharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Phytopharm partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Europlant GroupcorePhytopharm Klęka S.A. is part of the Europlant Group, as evidenced by the corporate logo and branding. Europlant Group is a pan-European pharmaceutical group focused on plant-based medicines and health products. The company operates under the Europlant Group umbrella and shares corporate contact infrastructure.
Scale indicators1 record
Recent moves4 records
Expansion highlights3 records
Phytopharm competitors and assessment
Company assessmentDirect peers
- Natur Produkt Pharma Sp. z o.o. Polish herbal and OTC pharmaceutical producer with a similar domestic pharmacy and wholesale channel mix. A direct domestic competitor and the most geographically overlapping peer.
- Dr. Willmar Schwabe GmbH & Co. KG: German manufacturer of plant-based medicinal products with strong research orientation. Directly comparable on herbal API and finished dosage form manufacturing for European pharmacy channels.
- Indena S.p.A. Italian producer of standardized botanical extracts and APIs for the pharmaceutical and nutraceutical industries. Directly comparable to Phytopharm's extracts/APIs and contract manufacturing business.
- Steigerwald Arzneimittelwerk GmbH: German phytopharmaceutical manufacturer now owned by Bayer Consumer Health. Directly comparable in plant-based medicine portfolio and pharmacy channel focus.
- Bionorica SE: German-based herbal pharmaceutical company manufacturing plant-based prescription and OTC medicines. Highly comparable in product category (phytopharmaceuticals), regulatory model, and European distribution footprint.
- Salus Haus GmbH & Co. KG: German manufacturer of plant-based medicinal and health products sold through pharmacies. Comparable in product positioning, plant-based manufacturing focus, and European pharmacy distribution.
Broad incumbents
- Bayer AG (Consumer Health): Global consumer health incumbent that owns herbal brands (e.g., Steigerwald). A broader incumbent competing for the same European pharmacy shelf space with substantially larger marketing and R&D resources.
- Gedeon Richter Plc. Hungarian-headquartered pharmaceutical group with a portfolio that includes herbal and plant-based products across CEE. A broader incumbent with overlapping phytopharmaceutical capabilities and pan-CEE distribution.
- Boehringer Ingelheim: Large global pharmaceutical company with consumer health and herbal product lines. A broader incumbent whose scale, regulatory resources, and acquisition activity in plant-based medicines represent a competitive threat.
- Merck KGaA: Diversified science and technology company with healthcare and life science exposure, including consumer health adjacencies. A broad incumbent with potential overlap in botanical ingredients and finished dosage forms.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Phytopharm social profiles
Digital presencePhytopharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Phytopharm leadership team
Management profileNumber of profiles
Profiles3 records
Phytopharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Phytopharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Phytopharm
What does Phytopharm do?
Phytopharm Klęka S.A. develops, manufactures and markets plant-based (herbal/phytopharmaceutical) medicinal products for prevention and treatment of various health conditions. Its portfolio includes finished herbal medicinal products sold under its own brand through wholesale and pharmacy channels. In addition, the company provides contract manufacturing services for other pharmaceutical partners and out-licenses its proprietary plant-derived products and active pharmaceutical ingredients (APIs).
Is Phytopharm a public or private company?
Phytopharm is a private company. It is classified as corporate owned and is currently operating.
When was Phytopharm founded?
Phytopharm was founded in 1949. It employs 101 to 250 people.
Where is Phytopharm based?
Phytopharm is headquartered in Nowe Miasto Nad Warta, Poland, in the Europe region.
How does Phytopharm make money?
One revenue line is on record: pharmaceutical product sales.
Who are Phytopharm's main competitors?
Direct peers on record are Natur Produkt Pharma Sp. z o.o., Dr. Willmar Schwabe GmbH & Co. KG, Indena S.p.A., Steigerwald Arzneimittelwerk GmbH, Bionorica SE and Salus Haus GmbH & Co. KG. Broad incumbents are Bayer AG (Consumer Health), Gedeon Richter Plc., Boehringer Ingelheim and Merck KGaA.
Does Phytopharm have an API?
No public API is recorded for Phytopharm.
What industry is Phytopharm in?
Phytopharm's product category is Herbal Pharmaceuticals. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts). Its NAICS code is 325411 and its SIC code is 2833.